vs

Side-by-side financial comparison of PROCEPT BioRobotics Corp (PRCT) and STRATASYS LTD. (SSYS). Click either name above to swap in a different company.

STRATASYS LTD. is the larger business by last-quarter revenue ($137.0M vs $76.4M, roughly 1.8× PROCEPT BioRobotics Corp). PROCEPT BioRobotics Corp runs the higher net margin — -39.1% vs -40.6%, a 1.5% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (11.9% vs -2.2%). STRATASYS LTD. produced more free cash flow last quarter ($2.5M vs $-12.2M). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (31.0% CAGR vs -7.4%).

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

Stratasys, Ltd. is an American-Israeli manufacturer of 3D printers, software, and materials for polymer additive manufacturing as well as 3D-printed parts on-demand. The company is incorporated in Israel. Engineers use Stratasys systems to model complex geometries in a wide range of polymer materials, including: ABS, polyphenylsulfone (PPSF), polycarbonate (PC), polyetherimide and Nylon 12.

PRCT vs SSYS — Head-to-Head

Bigger by revenue
SSYS
SSYS
1.8× larger
SSYS
$137.0M
$76.4M
PRCT
Growing faster (revenue YoY)
PRCT
PRCT
+14.1% gap
PRCT
11.9%
-2.2%
SSYS
Higher net margin
PRCT
PRCT
1.5% more per $
PRCT
-39.1%
-40.6%
SSYS
More free cash flow
SSYS
SSYS
$14.6M more FCF
SSYS
$2.5M
$-12.2M
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
31.0%
-7.4%
SSYS

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
PRCT
PRCT
SSYS
SSYS
Revenue
$76.4M
$137.0M
Net Profit
$-29.8M
$-55.6M
Gross Margin
60.6%
41.0%
Operating Margin
-40.6%
-16.6%
Net Margin
-39.1%
-40.6%
Revenue YoY
11.9%
-2.2%
Net Profit YoY
-58.3%
-109.0%
EPS (diluted)
$-0.54

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PRCT
PRCT
SSYS
SSYS
Q4 25
$76.4M
Q3 25
$83.3M
$137.0M
Q2 25
$79.2M
$138.1M
Q1 25
$69.2M
$136.0M
Q4 24
$68.2M
Q3 24
$58.4M
$140.0M
Q2 24
$53.4M
$138.0M
Q1 24
$44.5M
$144.1M
Net Profit
PRCT
PRCT
SSYS
SSYS
Q4 25
$-29.8M
Q3 25
$-21.4M
$-55.6M
Q2 25
$-19.6M
$-16.7M
Q1 25
$-24.7M
$-13.1M
Q4 24
$-18.9M
Q3 24
$-21.0M
$-26.6M
Q2 24
$-25.6M
$-25.7M
Q1 24
$-26.0M
$-26.0M
Gross Margin
PRCT
PRCT
SSYS
SSYS
Q4 25
60.6%
Q3 25
64.8%
41.0%
Q2 25
65.4%
43.1%
Q1 25
63.9%
44.3%
Q4 24
64.0%
Q3 24
63.2%
44.8%
Q2 24
59.0%
43.8%
Q1 24
56.2%
44.4%
Operating Margin
PRCT
PRCT
SSYS
SSYS
Q4 25
-40.6%
Q3 25
-27.8%
-16.6%
Q2 25
-28.0%
-12.0%
Q1 25
-39.7%
-9.1%
Q4 24
-28.9%
Q3 24
-38.4%
-18.2%
Q2 24
-50.3%
-18.9%
Q1 24
-62.1%
-17.0%
Net Margin
PRCT
PRCT
SSYS
SSYS
Q4 25
-39.1%
Q3 25
-25.7%
-40.6%
Q2 25
-24.7%
-12.1%
Q1 25
-35.8%
-9.6%
Q4 24
-27.6%
Q3 24
-35.9%
-19.0%
Q2 24
-48.0%
-18.6%
Q1 24
-58.3%
-18.0%
EPS (diluted)
PRCT
PRCT
SSYS
SSYS
Q4 25
$-0.54
Q3 25
$-0.38
Q2 25
$-0.35
Q1 25
$-0.45
Q4 24
$-0.34
Q3 24
$-0.40
Q2 24
$-0.50
Q1 24
$-0.51

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PRCT
PRCT
SSYS
SSYS
Cash + ST InvestmentsLiquidity on hand
$286.5M
$71.5M
Total DebtLower is stronger
$51.6M
Stockholders' EquityBook value
$365.9M
$852.5M
Total Assets
$508.1M
$1.1B
Debt / EquityLower = less leverage
0.14×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PRCT
PRCT
SSYS
SSYS
Q4 25
$286.5M
Q3 25
$294.3M
$71.5M
Q2 25
$302.7M
$71.1M
Q1 25
$316.2M
$70.1M
Q4 24
$333.7M
Q3 24
$196.8M
$64.0M
Q2 24
$214.1M
$70.9M
Q1 24
$225.6M
$91.1M
Total Debt
PRCT
PRCT
SSYS
SSYS
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Q1 24
$51.4M
Stockholders' Equity
PRCT
PRCT
SSYS
SSYS
Q4 25
$365.9M
Q3 25
$380.3M
$852.5M
Q2 25
$385.8M
$902.4M
Q1 25
$389.2M
$784.8M
Q4 24
$402.2M
Q3 24
$241.2M
$831.8M
Q2 24
$251.8M
$850.5M
Q1 24
$264.0M
$866.1M
Total Assets
PRCT
PRCT
SSYS
SSYS
Q4 25
$508.1M
Q3 25
$511.5M
$1.1B
Q2 25
$513.1M
$1.1B
Q1 25
$519.4M
$1.0B
Q4 24
$534.0M
Q3 24
$374.1M
$1.1B
Q2 24
$374.4M
$1.1B
Q1 24
$382.9M
$1.1B
Debt / Equity
PRCT
PRCT
SSYS
SSYS
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×
Q1 24
0.19×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PRCT
PRCT
SSYS
SSYS
Operating Cash FlowLast quarter
$-10.3M
$6.9M
Free Cash FlowOCF − Capex
$-12.2M
$2.5M
FCF MarginFCF / Revenue
-15.9%
1.8%
Capex IntensityCapex / Revenue
2.4%
3.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-58.3M
$-11.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PRCT
PRCT
SSYS
SSYS
Q4 25
$-10.3M
Q3 25
$-6.6M
$6.9M
Q2 25
$-15.0M
$-1.1M
Q1 25
$-17.0M
$4.5M
Q4 24
$-32.4M
Q3 24
$-18.8M
$-4.5M
Q2 24
$-15.7M
$-2.4M
Q1 24
$-32.3M
$7.3M
Free Cash Flow
PRCT
PRCT
SSYS
SSYS
Q4 25
$-12.2M
Q3 25
$-9.5M
$2.5M
Q2 25
$-17.8M
$-8.4M
Q1 25
$-18.8M
$789.0K
Q4 24
$-33.6M
Q3 24
$-19.0M
$-6.3M
Q2 24
$-16.8M
$-4.9M
Q1 24
$-34.2M
$5.0M
FCF Margin
PRCT
PRCT
SSYS
SSYS
Q4 25
-15.9%
Q3 25
-11.4%
1.8%
Q2 25
-22.5%
-6.1%
Q1 25
-27.2%
0.6%
Q4 24
-49.2%
Q3 24
-32.6%
-4.5%
Q2 24
-31.4%
-3.6%
Q1 24
-76.9%
3.5%
Capex Intensity
PRCT
PRCT
SSYS
SSYS
Q4 25
2.4%
Q3 25
3.4%
3.2%
Q2 25
3.5%
5.3%
Q1 25
2.7%
2.8%
Q4 24
1.7%
Q3 24
0.4%
1.3%
Q2 24
2.0%
1.8%
Q1 24
4.4%
1.6%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PRCT
PRCT

Hand Pieces And Other Consumables$34.1M45%
System Sales And Rentals$27.5M36%
Other$9.8M13%
Service Revenue$5.0M7%

SSYS
SSYS

Segment breakdown not available.

Related Comparisons